Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Deloitte
Argus Health
Moodys
Cipla
Colorcon
US Department of Justice
Merck

Generated: April 27, 2018

DrugPatentWatch Database Preview

MYAMBUTOL Drug Profile

« Back to Dashboard

Which patents cover Myambutol, and when can generic versions of Myambutol launch?

Myambutol is a drug marketed by Sti Pharma Llc and is included in one NDA.

The generic ingredient in MYAMBUTOL is ethambutol hydrochloride. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.
Drug patent expirations by year for MYAMBUTOL
Pharmacology for MYAMBUTOL
Medical Subject Heading (MeSH) Categories for MYAMBUTOL
Synonyms for MYAMBUTOL
(+)-(S,S)-2,2'-(1,2-Ethylenediimino)-di-1-butanol
(+)-2,2'-(Ethylenediimino)di-1-butanol
(+)-ethambutol
(+)-N,N'-Bis(1-(hydroxymethyl)propyl)ethylenediamine
(+)-S,S-Ethambutol
(2S,2'S)-2,2'-(Ethane-1,2-diylbis(azanediyl))bis(butan-1-ol)
(2S,2'S)-2,2'-(ethane-1,2-diyldiimino)dibutan-1-ol
(2S,7S)-2,7-diethyl-3,6-diazaoctane-1,8-diol
(2S)-2-[(2-{[(2S)-1-hydroxybutan-2-yl]amino}ethyl)amino]butan-1-ol
(2S)-2-[2-[[(1S)-1-(hydroxymethyl)propyl]amino]ethylamino]butan-1-ol
(2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
(R)-2,2'-(1,2-Ethanediyldiimino)bis-1-butanol
(S,S)-2,2 inverted exclamation mark -(1,2-Ethanediyldiimino)-bis-1-butanol Dihydrochloride
(S,S)-ethambutol
1-Butanol, 2,2'-(1,2-ethanediyldiimino)bis-, (2S,2'S)-
1-Butanol, 2,2'-(1,2-ethanediyldiimino)bis-, (R-(R*,R*))-
2-[2-(1-Hydroxymethyl-propylamino)-ethylamino]-butan-1-ol
2860AH
74-55-5
8G167061QZ
AB00053473_04
AB00053473_05
AC1L230T
AC1Q77PZ
Aethambutolum
AEUTYOVWOVBAKS-UWVGGRQHSA-N
AJ-72914
AK135245
AKOS016845874
AX8127590
BDBM50448407
BSPBio_002012
C06984
CHEBI:4877
CHEMBL44884
CL 40881 (dihydrochloride)
CS-2630
D-2,2'-(Ethylenediimino)bis(1-butanol)
D-2,2'-(Ethylenediimino)di-1-butanol
D-Ethambutol
D-N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine
d,N,N'-Bis(1-hydroxymethylpropyl)ethylenediamine
D07925
DB00330
Diambutol
DivK1c_000561
DR000333
DTXSID8023006
E-3950
Ebutol
EINECS 200-810-6
EMB
EN300-150035
Etambutol
Etambutol [INN-Spanish]
Etambutolo
Etambutolo [DCIT]
Etapiam
ethambutol
Ethambutol (INN)
Ethambutol [INN:BAN]
Ethambutol dihydrochloride
Ethambutol dihydrochloride, Antibiotic for Culture Media Use Only
Ethambutol HCL
Ethambutol Hydrochloride
Ethambutol, racemic mixture
Ethambutolum
Ethambutolum [INN-Latin]
FT-0625721
HSDB 3078
HY-B0535
IDI1_000561
KB-206588
KBio1_000561
KBio2_001538
KBio2_004106
KBio2_006674
KBio3_001232
KBioGR_001209
KBioSS_001538
LS-187119
MCULE-9663372083
Myambutol (dihydrochloride)
Mycobutol
NCGC00178864-01
NCGC00178864-03
NINDS_000561
OR336334
Purderal
RL04833
S,S-Ethambutol
SBI-0051375.P003
SCHEMBL3399
Servambutol (TN)
SPBio_001167
Spectrum_001058
Spectrum2_001014
Spectrum3_000426
Spectrum4_000545
Spectrum5_000702
Sural
Tibutol
UNII-8G167061QZ
ZINC19364219

US Patents and Regulatory Information for MYAMBUTOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sti Pharma Llc MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sti Pharma Llc MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sti Pharma Llc MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sti Pharma Llc MYAMBUTOL ethambutol hydrochloride TABLET;ORAL 016320-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Department of Justice
Daiichi Sankyo
McKesson
Covington
McKinsey
Fuji
Fish and Richardson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.